The Effect of Standardizing Procedures for SC Injections of LMWH on Patients With CVD
Recruiting now · Not applicable
Conditions studied: CVD - Cardiovascular Disease, Bruise, Pain
In brief
Improper subcutaneous administration of LMWH may cause complications at the injection site. Standardized protocol for subcutaneous LMWH injections in patient with cardiovascular diseases is warranted to ensure consistent best practices in clinical settings.
Key facts
- Study ID
- NCT06776159
- Run by
- The Hong Kong Polytechnic University
- People needed
- 180
- Starts
- 2025-06-24
- Expected to finish
- 2026-01-31
- Last updated by the study team
- 2025-09-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- patients who are in cardiac care units suffering from cardiovascular diseases prescribed with LMWH injections two times per day
- Chinese
You may not qualify if…
- cognitively impaired
- unconscious
- refuse to participate
Where it is running
- Hospital Authority, Hong Kong — Hong Kong, Hong Kong (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.